company background image
603882 logo

Guangzhou Kingmed Diagnostics Group SHSE:603882 Stock Report

Last Price

CN¥27.61

Market Cap

CN¥12.8b

7D

7.6%

1Y

-53.8%

Updated

09 Sep, 2024

Data

Company Financials +

Guangzhou Kingmed Diagnostics Group Co., Ltd.

SHSE:603882 Stock Report

Market Cap: CN¥12.8b

Guangzhou Kingmed Diagnostics Group Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guangzhou Kingmed Diagnostics Group
Historical stock prices
Current Share PriceCN¥27.61
52 Week HighCN¥69.60
52 Week LowCN¥24.61
Beta0.55
11 Month Change-4.69%
3 Month Change-11.31%
1 Year Change-53.75%
33 Year Change-71.65%
5 Year Change-48.20%
Change since IPO176.65%

Recent News & Updates

Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Sep 03
Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

Aug 25
Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

Recent updates

Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Sep 03
Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

Aug 25
Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Jun 04
A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

May 02
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Apr 17
Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

Feb 28
Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

Shareholder Returns

603882CN HealthcareCN Market
7D7.6%-1.4%-2.4%
1Y-53.8%-34.0%-20.1%

Return vs Industry: 603882 underperformed the CN Healthcare industry which returned -34% over the past year.

Return vs Market: 603882 underperformed the CN Market which returned -20.1% over the past year.

Price Volatility

Is 603882's price volatile compared to industry and market?
603882 volatility
603882 Average Weekly Movement7.2%
Healthcare Industry Average Movement4.8%
Market Average Movement5.4%
10% most volatile stocks in CN Market8.6%
10% least volatile stocks in CN Market3.6%

Stable Share Price: 603882 has not had significant price volatility in the past 3 months.

Volatility Over Time: 603882's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
200611,586Yaoming Liangwww.kingmed.com.cn

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. The company also offers clinical research, health management, cold chain logistics, and scientific research services, as well as vitro diagnostics, big data, artificial intelligence, and forensic testing services.

Guangzhou Kingmed Diagnostics Group Co., Ltd. Fundamentals Summary

How do Guangzhou Kingmed Diagnostics Group's earnings and revenue compare to its market cap?
603882 fundamental statistics
Market capCN¥12.83b
Earnings (TTM)CN¥448.19m
Revenue (TTM)CN¥8.25b

28.6x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603882 income statement (TTM)
RevenueCN¥8.25b
Cost of RevenueCN¥5.32b
Gross ProfitCN¥2.93b
Other ExpensesCN¥2.48b
EarningsCN¥448.19m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.96
Gross Margin35.54%
Net Profit Margin5.43%
Debt/Equity Ratio5.7%

How did 603882 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

92%

Payout Ratio